Biotechnology · Healthcare
CEO, Board Member
2020-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Reviva Pharmaceuticals Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get RVPH alertsLaxminarayan Bhat is recorded as Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH) since January 1, 2020 and CEO at Reviva Pharmaceuticals Holdings, Inc. (RVPH). The newest filing on record that lists Laxminarayan Bhat as CEO and Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH) is dated November 9, 2026. The proxy statement of Reviva Pharmaceuticals Holdings, Inc. reports total compensation of $1,442,121 for Laxminarayan Bhat in fiscal 2025, including a base salary of $565,000. Disclosed compensation is on record for 7 fiscal years. Laxminarayan Bhat has spoken on 2 investor events across 1 company, most recently for Reviva Pharmaceuticals Holdings, Inc. on September 29, 2026. Reviva Pharmaceuticals Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Reviva Pharmaceuticals Holdings, Inc. includes Parag Saxena (Chairman), Narayan Prabhu (CFO), Les Funtleyder (Board Member) and 3 others.
“Before I start my presentation, I would like you all to view the forward-looking statements displayed here. So, in this presentation, I would like to give a brief overview of what we do here at Reviva.”
“I really appreciate the opportunity to present here at lithium conference and then looking forward to connecting the viewers and then investors in this conference so before i begin my presentation i would like all the viewers to take a look at our forward-looking statements displayed here so i'll give a very brief…”
2020-01-01–present
Last confirmed November 9, 2026
Start not stated–present
Last confirmed November 9, 2026
Biotechnology · Healthcare
CEO, Board Member
2020-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $565,000 | $1,442,121 |
| 2024 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $450,000 | $607,500 |
| 2023 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $450,000 | $2,764,747 |
| 2022 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $400,000 | $560,000 |
| 2021 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $400,000 | $600,054 |
| 2020 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $247,952 | $247,952 |
| 2019 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Executive Officer and President | $240,000 | $240,000 |